• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板诱导的同种免疫过程中的免疫学特征,重点关注血小板成分输血。

Immunological Features in the Process of Blood Platelet-Induced Alloimmunisation, with a Focus on Platelet Component Transfusion.

作者信息

Garraud Olivier, Cognasse Fabrice, Moncharmont Pierre

机构信息

EA_3064, Faculty of Medicine of Saint-Etienne, University of Lyon, 42023 Saint-Etienne, France.

Institut National de la Transfusion Sanguine, 75015 Paris, France.

出版信息

Diseases. 2019 Jan 14;7(1):7. doi: 10.3390/diseases7010007.

DOI:10.3390/diseases7010007
PMID:30646515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6473846/
Abstract

Alloimmunisation to platelet antigens is not uncommon; a large number of females, having had pregnancies, developed antibodies to Human Leukocyte Antigen (HLA) moieties harboured on their foetuses' cells (inherited from the father(s)) that may conflict with further pregnancies and transfused Platelet Components occasionally. This is possible since platelets constitutionally express HLA class I molecules (though in copy numbers that consistently differ among individuals). Platelets also express HPA moieties that are variants of naturally expressed adhesion and aggregation molecules; HPA differences between mothers and foetuses and between donors and recipients explain alloimmune conflicts and consequences. Lastly, platelets express ABO blood group antigens, which are rarely immunising, however transfusion mismatches in ABO groups seem to be related to immunisation in other blood and tissue groups. Transfusion also brings residual leukocytes that may also immunise through their copious copy numbers of HLA class I (rarely class II on activated T lymphocytes, B cells, and dendritic cells). In addition, residual red blood cells in platelet concentrates may induce anti-red blood cell allo-antibodies. This short review aims to present the main mechanisms that are commonly reported in alloimmunisation. It also critically endeavours to examine paths to either dampen alloimmunisation occurrences or to prevent them.

摘要

血小板抗原同种免疫并不罕见;许多有过妊娠经历的女性会产生针对胎儿细胞(从父亲遗传而来)所携带的人类白细胞抗原(HLA)部分的抗体,这些抗体偶尔可能会影响后续妊娠及输注的血小板成分。这是有可能的,因为血小板固有地表达HLA I类分子(尽管个体之间其拷贝数始终存在差异)。血小板还表达人类血小板抗原(HPA)部分,这些是天然表达的黏附及聚集分子的变体;母亲与胎儿之间以及供者与受者之间的HPA差异解释了同种免疫冲突及后果。最后,血小板表达ABO血型抗原,其很少引起免疫反应,然而ABO血型的输血不匹配似乎与其他血液及组织类型的免疫反应有关。输血还会带来残留白细胞,这些白细胞也可能因其大量的HLA I类拷贝数(在活化的T淋巴细胞、B细胞和树突状细胞上很少有II类)而引起免疫反应。此外,血小板浓缩物中的残留红细胞可能诱导抗红细胞同种抗体。这篇简短综述旨在介绍同种免疫中常见报道的主要机制。它还批判性地努力探讨减轻或预防同种免疫发生的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f74/6473846/39929ffe73f3/diseases-07-00007-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f74/6473846/c66ed70ecb94/diseases-07-00007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f74/6473846/ffc06c4adb29/diseases-07-00007-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f74/6473846/4fcfc5602627/diseases-07-00007-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f74/6473846/39929ffe73f3/diseases-07-00007-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f74/6473846/c66ed70ecb94/diseases-07-00007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f74/6473846/ffc06c4adb29/diseases-07-00007-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f74/6473846/4fcfc5602627/diseases-07-00007-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f74/6473846/39929ffe73f3/diseases-07-00007-g004.jpg

相似文献

1
Immunological Features in the Process of Blood Platelet-Induced Alloimmunisation, with a Focus on Platelet Component Transfusion.血小板诱导的同种免疫过程中的免疫学特征,重点关注血小板成分输血。
Diseases. 2019 Jan 14;7(1):7. doi: 10.3390/diseases7010007.
2
An overview of red blood cell and platelet alloimmunisation in transfusion.输血相关的红细胞和血小板同种免疫概述。
Transfus Clin Biol. 2022 Nov;29(4):297-306. doi: 10.1016/j.tracli.2022.08.140. Epub 2022 Aug 12.
3
Acquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008-2013 national haemovigilance survey.80岁及以上输血患者获得性红细胞同种抗体:2008 - 2013年全国血液警戒调查
Blood Transfus. 2017 May;15(3):254-258. doi: 10.2450/2016.0328-15. Epub 2017 Jul 5.
4
Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model.输注的血小板增强了在小鼠模型中对输注表达 KEL 的红细胞的同种免疫反应。
Blood Transfus. 2019 Sep;17(5):368-377. doi: 10.2450/2018.0178-18. Epub 2018 Nov 7.
5
Platelet transfusions: the problem of refractoriness.血小板输注:难治性问题
Blood Rev. 1990 Mar;4(1):16-24. doi: 10.1016/0268-960x(90)90013-i.
6
Prevention and management of platelet transfusion refractoriness.血小板输注无效的预防与管理
Vox Sang. 1999;76(1):1-13. doi: 10.1159/000031013.
7
Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).血小板输注后红细胞同种免疫(ABO 血型系统除外)。
Transfus Clin Biol. 2020 Aug;27(3):185-190. doi: 10.1016/j.tracli.2020.06.001. Epub 2020 Jun 13.
8
Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.巴基斯坦定期输血的β地中海贫血患者中的红细胞同种免疫
Transfus Med. 2015 Apr;25(2):106-10. doi: 10.1111/tme.12196. Epub 2015 Apr 14.
9
[Prevention of HLA-alloimmunization of recipients of platelet concentrates].[预防血小板浓缩物接受者的HLA同种免疫]
Beitr Infusionsther. 1991;28:209-12.
10
Determination viability of a transfused platelet product by corrected count increment and percentage platelet response.通过校正计数增加值和血小板反应百分比来确定输注血小板产品的活力。
Pan Afr Med J. 2017 Jul 28;27:226. doi: 10.11604/pamj.2017.27.226.12116. eCollection 2017.

引用本文的文献

1
HLA class I expression on human platelets is highly variable and correlates with distinct allele group frequencies.人类血小板上 HLA I 类分子的表达具有高度变异性,并与不同的等位基因频率相关。
Blood Transfus. 2024 Sep;22(5):440-449. doi: 10.2450/BloodTransfus.571. Epub 2024 Jan 11.
2
Divergent CD4 T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients.在接受血小板输注的 AML 患者中,不同的 CD4 T 细胞谱与抗 HLA 同种免疫状态相关。
Front Immunol. 2023 Aug 28;14:1165973. doi: 10.3389/fimmu.2023.1165973. eCollection 2023.
3
Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice.

本文引用的文献

1
Types of fresh plasma with focus on therapeutic plasma exchange.聚焦治疗性血浆置换的新鲜血浆类型。
Transfus Apher Sci. 2019 Jun;58(3):258-261. doi: 10.1016/j.transci.2019.04.009. Epub 2019 Apr 19.
2
Pathogen reduction or inactivation technologies for platelet components: Does decision making have to await further clinical trials?血小板成分的病原体灭活技术:决策是否必须等待进一步的临床试验?
Transfus Apher Sci. 2018 Dec;57(6):797-798. doi: 10.1016/j.transci.2018.10.016. Epub 2018 Oct 30.
3
HLA-Mediated Platelet Refractoriness.
减菌 PRP 通过小鼠树突状细胞和单核细胞抑制 T 细胞激活,诱导 Treg 细胞,并促进 TGF-β 表达。
Blood Adv. 2020 Nov 10;4(21):5547-5561. doi: 10.1182/bloodadvances.2020002867.
4
How do I see the production of engineered blood cells available for transfusion?我如何看待可用于输血的工程细胞的生产?
Transfus Apher Sci. 2020 Aug;59(4):102863. doi: 10.1016/j.transci.2020.102863. Epub 2020 Jun 29.
5
Seroconversion of red blood cell antibody in ABO-incompatible living donor liver transplantation -a case report.ABO 血型不相容活体肝移植中红细胞抗体的血清学转换:1 例报告。
Korean J Anesthesiol. 2020 Jun;73(3):252-256. doi: 10.4097/kja.19141. Epub 2019 Jul 15.
HLA 介导的血小板反应性降低。
Am J Clin Pathol. 2019 Mar 1;151(4):353-363. doi: 10.1093/ajcp/aqy121.
4
Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.具有互补和协同相互作用几何形状的抗 HLA 抗体可促进血小板上经典补体的激活。
Haematologica. 2019 Feb;104(2):403-416. doi: 10.3324/haematol.2018.201665. Epub 2018 Sep 27.
5
Posttransfusion purpura with antibodies against human platelet antigen-4a following checkpoint inhibitor therapy: a case report and review of the literature.检查点抑制剂治疗后出现抗人血小板抗原-4a抗体的输血后紫癜:一例报告及文献复习
Transfusion. 2018 Oct;58(10):2265-2269. doi: 10.1111/trf.14824. Epub 2018 Sep 17.
6
How to mitigate the risk of inducing transfusion-associated adverse reactions.如何降低引发输血相关不良反应的风险。
Transfus Clin Biol. 2018 Nov;25(4):262-268. doi: 10.1016/j.tracli.2018.07.006. Epub 2018 Jul 27.
7
Pathogen inactivation/reduction technologies for platelet transfusion: Where do we stand?血小板输注的病原体灭活/去除技术:我们目前的进展如何?
Transfus Clin Biol. 2018 Sep;25(3):165-171. doi: 10.1016/j.tracli.2018.07.001. Epub 2018 Jul 21.
8
Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.储存诱导的血小板凋亡是血小板输注引起同种免疫的一个潜在危险因素。
Front Immunol. 2018 Jun 5;9:1251. doi: 10.3389/fimmu.2018.01251. eCollection 2018.
9
A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.一组抗 HLA 抗体诱导 FcγRIIa 依赖性血小板活化。
Haematologica. 2018 Oct;103(10):1741-1752. doi: 10.3324/haematol.2018.189365. Epub 2018 Jun 1.
10
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial.病原体灭活与未处理血小板的止血效果:一项随机对照试验。
Blood. 2018 Jul 12;132(2):223-231. doi: 10.1182/blood-2018-02-831289. Epub 2018 May 17.